In order to validate the feasibility of GDF15 as a serum biomarker, its concentration was measured in the serum of 17 patients with mitochondrial diseases as well as in that of 13 patients with other pediatric diseases as a control [46]. The gene discussed is GDF15; the disease is inborn mitochondrial metabolism disorder.